Investment

This week’s family/private investment office deals

Private Equity

Medich Family Office, a Sydney based investment office owned by the Medich family, has bought a part of McWilliam’s Wines, a famous Australian wine company. The terms of the deal weren’t disclosed. 

Unspecified Rounds

Dunross & Co, a Swedish investment group owned by Sven Norfeldt, has invested in FinanZero, a lending platform. Dunross was one of three investors committing R$40 million to the Brazilian group.

Series A 

Fremont Group, the family office of the Bechtel family, The Cynosure Group, which manages the money of the Utah-based Eccles family, and Still Capital Partners, an investment group owned by venture investor George J. Still, have invested in BrightPlan, a fintech group. The three investors joined one other in a commitment of $9.5 million to the San Jose, California-based group.

North Carolina-based investment office Simcah Management, owned by investor David Isaac Cohen, has invested in Cellphire, a biotech group. Simcah committed $15 million to the Maryland-based group.  

GingerBread Capital, an investment group owned by Linnea Conrad Roberts, who is married to George R. Roberts, a billionaire and one of the original partners of private equity group Kohlberg Kravis Roberts, has invested in Pair Eyewear, an eyewear brand for kids. GingerBread was one of seven investors committing $12 million to the New York City-based group. 

NRJN Trust, an investment group owned by Nandan Nilekani, the co-founder of Infosys, has invested in Avanti Finance, a lending platform. NRJN was one of five investors committing INR2 billion to the Indian group. 

Series B 

Kravis Investment Partners, owned by Robert Kravis of the private equity group KKR, and his wife Kimberly, has invested in StashFin, a digital lending company. Kravis Investment was one of nine investors committing $40 million to the Indian group. 

Horizons Ventures, Li Ka-Shing’s venture investment group, has invested in Syzygy Plasmonics, a chemical group. Horizons was one of five investors committing $23 million to the Houston, Texas-based group. 

Tao Capital Partners, owned by Nicholas Pritzker, has invested in Vizgen, a biotech group. Tao was one of six investors committing $37 million to the Cambridge, Massachusetts-based group. 

F-Prime Capital, the Johnson family, owners of Fidelity, venture group, has invested in Firefly Health, a healthcare group. F-Prime was one of three investors committing $40 million to the Massachusetts-based group. 

Series C

Presight Capital, a New York City-based venture group owned by German investor Christian Angermayer, Ulysses Diversified Holdings, owned by Errik & Emily Anderson, and Peter Thiel, possibly through his investment group, Thiel Capital. Have invested in Alloy Therapeutics, a biotech group. The three investors joined six others in a commitment of $95 million for the Lexington, Massachusetts-based group. 

Series D

Sofina, an investment group owned by the Belgian-based Boël family, has invested in CRED, a fintech group. Sofina was one of nine investors committing INR15.8 billion to the Indian group. 

Series E 

JS Capital Management, the investment office of Jonathan Soros, has invested in Inscripta, a biotech group. JS Capital was one of six investors committing $150 million to the Boulder, Colorado-based group. 

 

Subscribe

You will need a Premium Plus Subscription to access this database.

Exclusive news, analysis and research on global family enterprise and private investment offices.

Access to the most comprehensive fully interactive database on global family offices, principal investment offices, and family enterprises.

Check Deal Data, Senior Staff, and New Analysis on more than 500 family/principal investment and holding groups

Already have an account? Login

Subscribe

You need at least a Premium Subscription to read this article.

The most comprehensive information service on the global family enterprise world, featuring exclusive news, analysis, research and data on global family enterprises, family offices, and private investment offices.

Premium

£ 299

Annually

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
Subscribe now

Premium Plus

£ 399

Annually

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

Subscribe Now

Already have an account? Login

Subscribe

Exclusive news, analysis and research on global family enterprise and private investment offices.

Membership

Free

  • Exclusive reports, analysis and commentary
Sign up

Premium

£ 299

Annually

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
Subscribe now

Premium Plus

£ 399

Annually

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

Subscribe Now

Already have an account? Login

Leave a Reply